A Study on Rheumatoid Arthritis Patients Treated With Rituximab

Retrospective Data Collection on Rheumatoid Arthritis (RA) Patients Treated With Rituximab in Finland.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02622503

Enrollment

Registered

2015-12-04

Start date

2008-04-30

Completion date

2008-08-31

Last updated

2016-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Brief summary

The purpose of the study is to obtain an overall picture of rituximab treatments and treatment responses in RA patients.

Interventions

DRUGRituximab

This is an observational study. Patients with rheumatoid arthritis and having received treatment previously will be assessed for the treatment responses.

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Rheumatoid arthritis (RA) patients treated with rituximab in Finland

Exclusion criteria

* Not applicable

Design outcomes

Primary

Measure	Time frame
Information on previous RA treatments	3 months
Information on rituximab treatment responses	3 months
Information on concomitant medications	3 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026